Page last updated: 2024-08-23

simvastatin and Carcinoma, Epidermoid

simvastatin has been researched along with Carcinoma, Epidermoid in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
Andrades, E; Bódalo, M; Deza, G; Espadas, G; Gimeno, R; Haro, N; Hernández-Muñoz, I; Pozo, ÓJ; Pujol, RM; Sabidó, E; Segura, S; Toll, A; Torres, P1
Kou, Y; Li, M; Liu, B; Liu, H; Rong, X; Wang, C; Yang, P; Zhang, Y; Zhou, Q1
Fregni, G; Galland, S; Letovanec, I; Martin, P; Stamenkovic, I1
Fan, Y; Gao, K; Luo, S; Sun, C; Wang, H; Wang, T; Xiao, Q; Zhang, L; Zhang, Z1
Adalsteinsson, JA; Feng, H; Hu, C; Jonasson, JG; Kristjansson, AK; Muzumdar, S; Olafsdottir, GH; Ratner, D; Silverberg, JI; Tryggvadottir, L; Ungar, J; Waldman, R; Wu, R1
Gehrke, T; Hackenberg, S; Hagen, R; Ickrath, P; Kleinsasser, N; Schendzielorz, P; Scherzad, A1
Aigner, A; Boehm, A; Dietz, A; Mozet, C; Stoehr, M; Wichmann, G1
Desai, M; Hedlin, H; Kapphahn, K; Manson, JA; Martin, L; Simon, M; Stefanick, ML; Strickler, H; Tang, JY; Wactawski-Wende, J; Wang, A1
Gaggioli, C; Hooper, S; Sahai, E1
Kim, CW; Kim, YN; Li, YC; Park, MJ; Ye, SK1
Kakehata, S; Maruya, S; Mizukami, H; Myers, JN; Shinkawa, H; Shirasaki, T; Takahata, T; Takeda, I; Yagihashi, S1

Other Studies

11 other study(ies) available for simvastatin and Carcinoma, Epidermoid

ArticleYear
Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway.
    Life science alliance, 2023, Volume: 6, Issue:4

    Topics: Carcinoma, Squamous Cell; Cell Cycle Proteins; Humans; Mevalonic Acid; Nuclear Proteins; Phenotype; Simvastatin; Skin Neoplasms

2023
Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
    Journal of oral biosciences, 2023, Volume: 65, Issue:4

    Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Kruppel-Like Transcription Factors; Mice; Mouth Neoplasms; Simvastatin; Squamous Cell Carcinoma of Head and Neck

2023
Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
    Cancer letters, 2020, 08-01, Volume: 484

    Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cells, Cultured; Chemokine CCL2; Chemokine CCL3; Cytokines; Female; Gene Expression; Humans; Inflammation Mediators; Interleukin-6; Lung Neoplasms; Male; Mesenchymal Stem Cells; Middle Aged; Simvastatin; Tumor Cells, Cultured; Tumor Microenvironment

2020
Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
    Journal of cancer research and clinical oncology, 2021, Volume: 147, Issue:6

    Topics: Anoctamin-1; Carcinoma, Squamous Cell; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression Regulation, Neoplastic; HaCaT Cells; Humans; Ion Channel Gating; Mouth Neoplasms; Neoplasm Proteins; Neoplasm Staging; Simvastatin

2021
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
    Archives of dermatological research, 2022, Volume: 314, Issue:8

    Topics: Atorvastatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iceland; Simvastatin; Skin Neoplasms

2022
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
    International journal of oncology, 2017, Volume: 51, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; Simvastatin; Squamous Cell Carcinoma of Head and Neck

2017
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
    Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4

    Topics: Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; KB Cells; Male; Neoplasm Staging; Risk Factors; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Taxoids

2014
Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative.
    British journal of cancer, 2016, Feb-02, Volume: 114, Issue:3

    Topics: Age Factors; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Environmental Exposure; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Logistic Models; Longitudinal Studies; Lovastatin; Middle Aged; Odds Ratio; Overweight; Prospective Studies; Pyridines; Risk Factors; Simvastatin; Skin Neoplasms; Smoking; Sunlight; Vitamin D; Vitamins; White People

2016
A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion.
    British journal of cancer, 2010, Jan-19, Volume: 102, Issue:2

    Topics: Actomyosin; Carcinoma, Squamous Cell; Extracellular Matrix; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin alpha5; Lovastatin; Muscle Contraction; Neoplasm Invasiveness; rab GTP-Binding Proteins; Simvastatin

2010
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
    The American journal of pathology, 2006, Volume: 168, Issue:4

    Topics: Apoptosis; bcl-X Protein; beta-Cyclodextrins; Breast Neoplasms; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Cholesterol; Down-Regulation; Enzyme Activation; ErbB Receptors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Microdomains; Neoplasms; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Simvastatin

2006
Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.
    Cancer science, 2007, Volume: 98, Issue:6

    Topics: Anticholesteremic Agents; Carcinoma, Squamous Cell; Caspase 3; Cell Proliferation; Cell Survival; Focal Adhesion Kinase 1; G1 Phase; Head and Neck Neoplasms; Humans; Integrin beta1; Mevalonic Acid; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Simvastatin; Tumor Cells, Cultured

2007